WhatsApp
backNews Article

Indo-MIM Limited Confirms Proper Utilization of Rs. 500 Crore IPO Proceeds in Q2 2026

CARE Ratings Limited Monitoring Report for quarter ended September 30, 2026, shows no deviation from IPO fund utilization plans

Indo-MIM Limited has disclosed the Monitoring Agency Report for the quarter ended September 30, 2026, confirming that the Rs. 500 crore raised through its Initial Public Offer has been utilized as per the offer document with no deviations. The report by CARE Ratings Limited assures no material changes or approvals pending related to the IPO proceeds utilization.

4 days ago|INDOMIM-0.96%
Indo-MIM LimitedINDOMIMLegal / Regulatory

Indo-MIM Limited

Legal / Regulatory

Indo-MIM Limited has reported through a Monitoring Agency Report that the Rs. 500 crore raised from its Initial Public Offer has been utilized in accordance with the offer document for the quarter ended September 30, 2026.

The Monitoring Agency, CARE Ratings Limited, issued the report on November 13, 2026, confirming no material deviations in the utilization of IPO proceeds by Indo-MIM Limited.

The IPO was conducted from July 23, 2026, to July 27, 2026, raising Rs. 500 crore through equity shares as a public issue.

The proceeds are earmarked primarily for repayment or prepayment of outstanding borrowings (Rs. 400 crore), general corporate purposes (Rs. 85.437 crore), and issue expenses (Rs. 14.563 crore) as per the Red Herring Prospectus.

CARE Ratings noted that some company funds were routed through current accounts containing multiple transactions, leading to commingling of funds; nonetheless, the agency relied on alternative bank statements, RTGS receipts and email confirmations to verify fund utilization.

The report confirms that all utilization aligns with disclosures, with no shareholder approvals required for deviations since none occurred during the quarter under review.

Highlights

  • No deviation observed from the objects disclosed in the IPO offer document.
  • Rs. 500 crore raised through IPO comprises Rs. 400 crore for debt repayment, Rs. 85.437 crore for general corporate purposes, and Rs. 14.563 crore for issue expenses.
  • Monitoring Agency CARE Ratings Limited submitted the report on November 13, 2026, covering activity until September 30, 2026.
  • The company’s fund transactions involved commingled current accounts; CARE Ratings confirmed fund utilization through alternative verifications.
  • No government or statutory approvals are pending related to the IPO proceeds utilization.

Key Data Snapshot

IPO issue sizeRs. 500 crore
IPO issue periodJuly 23, 2026 to July 27, 2026
Primary use of funds - debt repaymentRs. 400 crore
Primary use of funds - general corporate purposeRs. 85.437 crore
Primary use of funds - issue expensesRs. 14.563 crore
Monitoring agencyCARE Ratings Limited
Report dateNovember 13, 2026
Quarter endedSeptember 30, 2026
Company Registrar OfficeKIADB Industrial Area, Hoskote, Bangalore 562 114

What happened

  • Indo-MIM Limited raised Rs. 500 crore through an Initial Public Offer conducted from July 23 to July 27, 2026.
  • CARE Ratings Limited, acting as the Monitoring Agency, issued a report confirming the IPO proceeds were utilized as per the offer document for the quarter ended September 30, 2026.
  • No material deviation or change to the utilization plan was detected during the reporting period.
  • The report was submitted on November 13, 2026, and is available on the company’s website.

Key details

  • The IPO proceeds are allocated for repayment/prepayment of borrowings (Rs. 400 crore), general corporate purposes (Rs. 85.437 crore), and issue expenses (Rs. 14.563 crore).
  • The proceeds were routed through current accounts containing other transactions, confirmed by alternative documentation.
  • No shareholder approvals were necessary as there were no deviations from projected expenditures.
  • There are no pending government or statutory approvals related to the IPO objectives.

Regulatory and governance context

  • The report complies with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.
  • CARE Ratings Limited stated no conflict of interest in performing the monitoring role.
  • The Monitoring Agency does not independently audit but relies on issuer-provided data and certifications.

More News on Legal / Regulatory

View all

Latest corporate announcements and market updates in Legal / Regulatory.

View all news
Indo-MIM Limited Confirms Proper Utilization of Rs. 500 | Stockk News